AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 15270962 — intervention group
Group type: EXPERIMENTAL
Intervention: Low molecular weight hydroxyethyl starch (Voluven)
Number of subjects: 20
Study 12027147 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium-vitamin D (CaD) supplementation (calcium carbonate 500 mg, citric acid 2.175 gr, cholecalciferol 200 IU)
Number of subjects: 100
Study 12027147 — intervention group
Group type: COMPARATOR
Intervention: Calcium (Ca) supplementation (calcium gluconolactate and carbonate 500 mg)
Number of subjects: 100
Study 12027147 — intervention group
Group type: COMPARATOR
Intervention: Calcium (Ca) supplementation
Number of subjects: 100
Study 10325518 — intervention group
Group type: EXPERIMENTAL
Intervention: Chemoprevention intervention
Number of subjects: 0
Study 10325518 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study 7572012 — intervention group
Group type: EXPERIMENTAL
Intervention: 6 mg of oral tizanidine
Number of subjects: 5
Study 7572012 — intervention group
Group type: EXPERIMENTAL
Intervention: 12 mg of oral tizanidine
Number of subjects: 5
Study 7572012 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 5
Study 2144295 — intervention group
Group type: EXPERIMENTAL
Intervention: DHEA 1600 mg/day (in four divided doses) for 28 days
Number of subjects: 6
Study 377968 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of norgestimate (0.125 mg) and ethinyl estradiol (0.035 mg)
Number of subjects: 1991
Study 377968 — intervention group
Group type: COMPARATOR
Intervention: Various dosage combinations of norgestimate and ethinyl estradiol
Number of subjects: 1991
Study 31605392 — intervention group
Group type: EXPERIMENTAL
Intervention: Ropivacaine 0.2% 5 mL
Number of subjects: 60
Study 31605392 — intervention group
Group type: EXPERIMENTAL
Intervention: Ropivacaine 0.2% 10 mL
Number of subjects: 60
Study 31605392 — intervention group
Group type: EXPERIMENTAL
Intervention: Ropivacaine 0.2% 15 mL
Number of subjects: 60
Study 31605392 — intervention group
Group type: EXPERIMENTAL
Intervention: Ropivacaine 0.2% 20 mL
Number of subjects: 60
Study 31605392 — intervention group
Group type: EXPERIMENTAL
Intervention: Ropivacaine 0.2% 30 mL
Number of subjects: 60
Study 31120908 — intervention group
Group type: COMPARATOR
Intervention: Enfuvirtide (T20) 90mg
Number of subjects: 26
Study 31120908 — intervention group
Group type: COMPARATOR
Intervention: Raltegravir (RAL) 400mg
Number of subjects: 26
Study 31120908 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 26
Study 28273822 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapeutic Horseback Riding (THR) intervention for 10 weeks
Number of subjects: 67
Study 28273822 — intervention group
Group type: COMPARATOR
Intervention: No-horse barn activity (BA) control group
Number of subjects: 67
Study 26351545 — intervention group
Group type: EXPERIMENTAL
Intervention: Real rTMS group
Number of subjects: 16
Study 26351545 — intervention group
Group type: COMPARATOR
Intervention: Sham group
Number of subjects: 16
Study 23332872 — intervention group
Group type: EXPERIMENTAL
Intervention: TKI re-treatment (sunitinib, sorafenib, dovitinib) after everolimus
Number of subjects: 36
Study 23332872 — intervention group
Group type: EXPERIMENTAL
Intervention: Sunitinib (17 patients)
Number of subjects: 36
Study 23332872 — intervention group
Group type: EXPERIMENTAL
Intervention: Sorafenib (15 patients)
Number of subjects: 36
Study 23332872 — intervention group
Group type: EXPERIMENTAL
Intervention: Dovitinib (4 patients)
Number of subjects: 36
Study 23332872 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall survival from the start of everolimus
Number of subjects: 36
Study 21295938 — intervention group
Group type: EXPERIMENTAL
Intervention: Web‐based assessment with counselor‐guided personalized normative feedback (CWF)
Number of subjects: 135
Study 21295938 — intervention group
Group type: COMPARATOR
Intervention: Web‐based assessment with self‐guided personalized normative feedback (SWF)
Number of subjects: 135
Study 19665825 — intervention group
Group type: EXPERIMENTAL
Intervention: Ankle-foot orthosis
Number of subjects: 20
Study 19665825 — intervention group
Group type: COMPARATOR
Intervention: No ankle-foot orthosis (control)
Number of subjects: 20
Study 17702798 — intervention group
Group type: EXPERIMENTAL
Intervention: Banded RPE
Number of subjects: 23
Study 17702798 — intervention group
Group type: COMPARATOR
Intervention: Bonded RPE
Number of subjects: 23
Study 15194252 — intervention group
Group type: EXPERIMENTAL
Intervention: Mandatory second opinion policy in intervention hospitals
Number of subjects: 149276
Study 15194252 — intervention group
Group type: COMPARATOR
Intervention: Control group (no mandatory second opinion)
Number of subjects: 149276
Study 11407727 — intervention group
Group type: EXPERIMENTAL
Intervention: Troglitazone (200 mg bid)
Number of subjects: 12
Study 11407727 — intervention group
Group type: EXPERIMENTAL
Intervention: Glibenclamide (2.5 mg daily)
Number of subjects: 12
Study 11407727 — intervention group
Group type: COMPARATOR
Intervention: Control group (age-, sex-, and risk factors-matched subjects without NIDDM)
Number of subjects: 12
Study 9587532 — intervention group
Group type: EXPERIMENTAL
Intervention: Lansoprazole 30 mg per day for 4 weeks
Number of subjects: 57
Study 8460390 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral magnesium supplementation (4g Mg granulate verum, 6.7 mmol Mg aspartate)
Number of subjects: 320
Study 8460390 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 320
Study 3809526 — intervention group
Group type: EXPERIMENTAL
Intervention: Caerulein 0.6 microgram/kg
Number of subjects: 6
Study 3809526 — intervention group
Group type: COMPARATOR
Intervention: Placebo (saline)
Number of subjects: 6
Study 31597637 — intervention group
Group type: EXPERIMENTAL
Intervention: National quality improvement programme
Number of subjects: 0
Study 31597637 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study 27837439 — intervention group
Group type: EXPERIMENTAL
Intervention: Prompt endocrine input
Number of subjects: 41
Study 27837439 — intervention group
Group type: COMPARATOR
Intervention: Routine care
Number of subjects: 41
Study 25613307 — intervention group
Group type: EXPERIMENTAL
Intervention: Patching during CEA
Number of subjects: 1151
Study 25613307 — intervention group
Group type: COMPARATOR
Intervention: Primary closure during CEA
Number of subjects: 1151
Study 23979789 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-energy dense diet (LED)
Number of subjects: 60
Study 23979789 — intervention group
Group type: EXPERIMENTAL
Intervention: Normal-energy dense diet (NED)
Number of subjects: 60
Study 23979789 — intervention group
Group type: EXPERIMENTAL
Intervention: High-energy dense diet (HED)
Number of subjects: 60
Study 23979789 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-energy dense diet (LED) and Normal-energy dense diet (NED)
Number of subjects: 60
Study 23979789 — intervention group
Group type: COMPARATOR
Intervention: Comparison across 3 groups (LED, NED, HED)
Number of subjects: 60
Study 23979789 — intervention group
Group type: COMPARATOR
Intervention: Dietary energy density (kcal/g)
Number of subjects: 60
Study 21863204 — intervention group
Group type: COMPARATOR
Intervention: Psychological treatments (defined as interventions involving verbal communication between a therapist and a patient)
Number of subjects: 3010
Study 21863204 — intervention group
Group type: COMPARATOR
Intervention: Control conditions (care-as-usual, waiting list, placebo, or another control group)
Number of subjects: 3010
Study 19481810 — intervention group
Group type: EXPERIMENTAL
Intervention: Dilated pupil glare testing using the Brightness Acuity Tester (BAT) after dilation
Number of subjects: 54
Study 19481810 — intervention group
Group type: COMPARATOR
Intervention: Undilated pupil glare testing using the Brightness Acuity Tester (BAT)
Number of subjects: 54
Study 19481810 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjustment of dilated BAT results by the change in visual acuity (VA) from dilation
Number of subjects: 54
Study 17655736 — intervention group
Group type: COMPARATOR
Intervention: Bed rest only (BR, n = 8)
Number of subjects: 24
Study 17655736 — intervention group
Group type: COMPARATOR
Intervention: Bed rest and nutrition countermeasure (BRN, n = 8)
Number of subjects: 24
Study 17655736 — intervention group
Group type: EXPERIMENTAL
Intervention: Bed rest and concurrent exercise training countermeasure (BRE, n = 8)
Number of subjects: 24
Study 15514963 — intervention group
Group type: EXPERIMENTAL
Intervention: Audio-visual relaxation training (RT)
Number of subjects: 100
Study 15514963 — intervention group
Group type: COMPARATOR
Intervention: Routine nursing care (Control)
Number of subjects: 100
Study 11716384 — intervention group
Group type: EXPERIMENTAL
Intervention: Posterior-stabilized AMK total knee implants
Number of subjects: 143
Study 11716384 — intervention group
Group type: COMPARATOR
Intervention: Cruciate-retaining AMK total knee implants
Number of subjects: 143
Study 9205150 — intervention group
Group type: EXPERIMENTAL
Intervention: Bovine pericardial strips used to buttress staple lines
Number of subjects: 123
Study 9205150 — intervention group
Group type: COMPARATOR
Intervention: No buttressing of staple lines
Number of subjects: 123
Study 8518571 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicotine patch
Number of subjects: 1686
Study 8518571 — intervention group
Group type: COMPARATOR
Intervention: Placebo patch
Number of subjects: 1686
Study 2883046 — intervention group
Group type: EXPERIMENTAL
Intervention: TCu220 IUD
Number of subjects: 0
Study 2883046 — intervention group
Group type: EXPERIMENTAL
Intervention: Delta T IUD
Number of subjects: 0
Study 2883046 — intervention group
Group type: COMPARATOR
Intervention: Both IUDs (TCu220 and Delta T)
Number of subjects: 0
Study 2565729 — intervention group
Group type: EXPERIMENTAL
Intervention: Adrenaline 0.3 mg subcutaneously
Number of subjects: 7
Study 2565729 — intervention group
Group type: EXPERIMENTAL
Intervention: Adrenaline 0.3 mg subcutaneously preceded by ICI 118,551 5 mg orally
Number of subjects: 7
Study 2565729 — intervention group
Group type: EXPERIMENTAL
Intervention: Salbutamol 8 mg orally
Number of subjects: 7
Study 2565729 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 7
Study 2565729 — intervention group
Group type: EXPERIMENTAL
Intervention: ICI 118,551
Number of subjects: 7
Study 2565729 — intervention group
Group type: EXPERIMENTAL
Intervention: Salbutamol
Number of subjects: 7
Study 30920571 — intervention group
Group type: EXPERIMENTAL
Intervention: 4.75% soybean germ oil
Number of subjects: 40
Study 30920571 — intervention group
Group type: EXPERIMENTAL
Intervention: 9.50% soybean germ oil
Number of subjects: 40
Study 30920571 — intervention group
Group type: EXPERIMENTAL
Intervention: Cholestyramine (0.50%)
Number of subjects: 40
Study 30920571 — intervention group
Group type: COMPARATOR
Intervention: High cholesterol diet
Number of subjects: 40
Study 30920571 — intervention group
Group type: COMPARATOR
Intervention: Non-cholesterol diet
Number of subjects: 40
Study 29167035 — intervention group
Group type: EXPERIMENTAL
Intervention: Balint groups (7 sessions of 1.5 hours over 3 months)
Number of subjects: 299
Study 29167035 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 299
Study 25420030 — intervention group
Group type: EXPERIMENTAL
Intervention: Present Control Intervention
Number of subjects: 257
Study 25420030 — intervention group
Group type: COMPARATOR
Intervention: Stress-information only comparison group
Number of subjects: 257
Study 23728992 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral intervention (theater play)
Number of subjects: 80
Study 23728992 — intervention group
Group type: COMPARATOR
Intervention: Environmental intervention
Number of subjects: 80
Study 23728992 — intervention group
Group type: COMPARATOR
Intervention: No intervention (wait-control group)
Number of subjects: 80
Study 21257263 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 tablet of ibuprofen 200mg/paracetamol 500mg
Number of subjects: 0
Study 21257263 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 tablets of ibuprofen 200mg/paracetamol 500mg
Number of subjects: 0
Study 21257263 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 tablets of ibuprofen 200mg/codeine 12.8mg
Number of subjects: 0
Study 21257263 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 tablets of paracetamol 500mg/codeine 15mg
Number of subjects: 0
Study 21257263 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 19320234 — intervention group
Group type: EXPERIMENTAL
Intervention: BILB 1941 60 mg
Number of subjects: 96
Study 19320234 — intervention group
Group type: EXPERIMENTAL
Intervention: BILB 1941 80 mg
Number of subjects: 96
Study 19320234 — intervention group
Group type: EXPERIMENTAL
Intervention: BILB 1941 100 mg
Number of subjects: 96
Study 19320234 — intervention group
Group type: EXPERIMENTAL
Intervention: BILB 1941 150 mg
Number of subjects: 96
Study 19320234 — intervention group
Group type: EXPERIMENTAL
Intervention: BILB 1941 200 mg
Number of subjects: 96
Study 19320234 — intervention group
Group type: EXPERIMENTAL
Intervention: BILB 1941 300 mg
Number of subjects: 96
Study 19320234 — intervention group
Group type: EXPERIMENTAL
Intervention: BILB 1941 450 mg
Number of subjects: 96
Study 19320234 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 96
Study 16813101 — intervention group
Group type: EXPERIMENTAL
Intervention: Ability grouping exercise program for lower fitness subjects (Group A)
Number of subjects: 124
Study 16813101 — intervention group
Group type: EXPERIMENTAL
Intervention: Ability grouping exercise program for higher fitness subjects (Group B)
Number of subjects: 124
Study 16813101 — intervention group
Group type: COMPARATOR
Intervention: Single exercise program (Group C)
Number of subjects: 124
Study 16813101 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups (A, B, C)
Number of subjects: 124
Study 15349901 — intervention group
Group type: EXPERIMENTAL
Intervention: TIPS
Number of subjects: 66
Study 15349901 — intervention group
Group type: COMPARATOR
Intervention: Paracentesis plus albumin
Number of subjects: 66
Study 10682299 — intervention group
Group type: EXPERIMENTAL
Intervention: Auditory temporal-spatial short-term memory tasks with sequences of bursts of white noise
Number of subjects: 8
Study 10682299 — intervention group
Group type: EXPERIMENTAL
Intervention: Auditory temporal-spatial short-term memory tasks with a 10-s delay
Number of subjects: 8
Study 10682299 — intervention group
Group type: EXPERIMENTAL
Intervention: Verbal and nonverbal secondary tasks
Number of subjects: 8
Study 10682299 — intervention group
Group type: EXPERIMENTAL
Intervention: Temporal errors in auditory memory tasks
Number of subjects: 8
Study 9333147 — intervention group
Group type: EXPERIMENTAL
Intervention: Didanosine (ddI) plus hydroxyurea (HU) combination therapy
Number of subjects: 20
Study 9333147 — intervention group
Group type: COMPARATOR
Intervention: Didanosine (ddI) monotherapy
Number of subjects: 20
Study 8226485 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeine (CAF) 5 mg/kg
Number of subjects: 14
Study 8226485 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PL)
Number of subjects: 14
Study 8226485 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeine (CAF) 2 x 2.5 mg/kg x day-1
Number of subjects: 14
Study 8226485 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeine (CAF)
Number of subjects: 14
Study 3801360 — intervention group
Group type: EXPERIMENTAL
Intervention: Norethisterone 5 mg/day
Number of subjects: 58
Study 3801360 — intervention group
Group type: EXPERIMENTAL
Intervention: Norethisterone 2.5 mg/day
Number of subjects: 58
Study 3801360 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 58
Study 28406860 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravitreal bevacizumab
Number of subjects: 119
Study 28406860 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravitreal ranibizumab
Number of subjects: 119
Study 26946952 — intervention group
Group type: EXPERIMENTAL
Intervention: Basic intervention
Number of subjects: 845
Study 26946952 — intervention group
Group type: EXPERIMENTAL
Intervention: Augmented intervention
Number of subjects: 845
Study 26946952 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 845
Study 26946952 — intervention group
Group type: EXPERIMENTAL
Intervention: All study participants
Number of subjects: 845
Study 25168619 — intervention group
Group type: EXPERIMENTAL
Intervention: MiniArc (single-incision midurethral sling)
Number of subjects: 193
Study 25168619 — intervention group
Group type: COMPARATOR
Intervention: Monarc (transobturator midurethral sling)
Number of subjects: 193
Study 23540683 — intervention group
Group type: EXPERIMENTAL
Intervention: l-lactate infusion (target concentration 3 mmol/L)
Number of subjects: 8
Study 23540683 — intervention group
Group type: COMPARATOR
Intervention: saline infusion
Number of subjects: 8
Study 20159123 — intervention group
Group type: EXPERIMENTAL
Intervention: Aquatic backward locomotion exercise
Number of subjects: 30
Study 20159123 — intervention group
Group type: EXPERIMENTAL
Intervention: Progressive resistance exercise
Number of subjects: 30
Study 20159123 — intervention group
Group type: COMPARATOR
Intervention: Control (CON) group
Number of subjects: 30
Study 19126894 — intervention group
Group type: EXPERIMENTAL
Intervention: Arthroscopic subacromial decompression (ASD) alone (n=50)
Number of subjects: 240
Study 19126894 — intervention group
Group type: COMPARATOR
Intervention: Arthroscopic subacromial decompression (ASD) plus ACJ excision (n=50, age-matched controls)
Number of subjects: 240
Study 16673689 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic surgery
Number of subjects: 0
Study 16673689 — intervention group
Group type: COMPARATOR
Intervention: Open surgery
Number of subjects: 0
Study 12197784 — intervention group
Group type: EXPERIMENTAL
Intervention: Ceramic-impregnated gloves
Number of subjects: 93
Study 12197784 — intervention group
Group type: COMPARATOR
Intervention: Placebo cotton gloves
Number of subjects: 93
Study 11477816 — intervention group
Group type: EXPERIMENTAL
Intervention: Shengbaikuai Decoction (SBK)
Number of subjects: 90
Study 11477816 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonchemotherapy group
Number of subjects: 90
Study 11477816 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 90
Study 11477816 — intervention group
Group type: COMPARATOR
Intervention: Blank group
Number of subjects: 90
Study 7893268 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiple dose powder inhaler (MDPI; Easyhaler)
Number of subjects: 40
Study 7893268 — intervention group
Group type: COMPARATOR
Intervention: Conventional metered dose inhaler (MDI)
Number of subjects: 40
Study 7893268 — intervention group
Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 40
Study 2649954 — intervention group
Group type: EXPERIMENTAL
Intervention: Tenoxicam 20 mg
Number of subjects: 1630
Study 2649954 — intervention group
Group type: COMPARATOR
Intervention: Piroxicam 20 mg
Number of subjects: 1630
Study 2649954 — intervention group
Group type: COMPARATOR
Intervention: Diclofenac sodium retard 100 mg
Number of subjects: 1630
Study 2649954 — intervention group
Group type: EXPERIMENTAL
Intervention: Tenoxicam
Number of subjects: 1630
Study 2649954 — intervention group
Group type: COMPARATOR
Intervention: Piroxicam
Number of subjects: 1630
Study 2649954 — intervention group
Group type: COMPARATOR
Intervention: Diclofenac sodium retard
Number of subjects: 1630
Study 1025317 — intervention group
Group type: EXPERIMENTAL
Intervention: Active needling
Number of subjects: 29
Study 1025317 — intervention group
Group type: EXPERIMENTAL
Intervention: Active needling followed by sham needling
Number of subjects: 29
Study 1025317 — intervention group
Group type: EXPERIMENTAL
Intervention: Sham needling followed by active needling
Number of subjects: 29
Study 1025317 — intervention group
Group type: COMPARATOR
Intervention: Sham needling
Number of subjects: 29
Study 31609689 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioral Activation (BA)
Number of subjects: 63
Study 31609689 — intervention group
Group type: COMPARATOR
Intervention: Treatment as Usual (TAU)
Number of subjects: 63
Study 30051975 — intervention group
Group type: EXPERIMENTAL
Intervention: 300 mg LY2495655 plus placebo
Number of subjects: 125
Study 30051975 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 mg LY2495655 plus placebo
Number of subjects: 125
Study 30051975 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 125
Study 30051975 — intervention group
Group type: EXPERIMENTAL
Intervention: LY2495655 (either dose)
Number of subjects: 125
Study 30051975 — intervention group
Group type: EXPERIMENTAL
Intervention: LY2495655
Number of subjects: 125
Study 27708124 — intervention group
Group type: EXPERIMENTAL
Intervention: Piña Colada (PC)
Number of subjects: 31
Study 27708124 — intervention group
Group type: EXPERIMENTAL
Intervention: Classic Tobacco (CT)
Number of subjects: 31
Study 27708124 — intervention group
Group type: EXPERIMENTAL
Intervention: All flavours
Number of subjects: 31
Study 27708124 — intervention group
Group type: EXPERIMENTAL
Intervention: Peach Schnapps (PS)
Number of subjects: 31
Study 27708124 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnificent Menthol (MM), Classic Tobacco (CT), Vivid Vanilla (VV)
Number of subjects: 31
Study 27708124 — intervention group
Group type: EXPERIMENTAL
Intervention: Cherry Crush (CC), Piña Colada (PC), Peach Schnapps (PS)
Number of subjects: 31
Study 27708124 — intervention group
Group type: EXPERIMENTAL
Intervention: Sweetness
Number of subjects: 31
Study 27708124 — intervention group
Group type: EXPERIMENTAL
Intervention: Harshness
Number of subjects: 31
Study 24737415 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvant imatinib 400 mg/day for 12 months
Number of subjects: 358
Study 24737415 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvant imatinib 400 mg/day for 36 months
Number of subjects: 358
Study 24737415 — intervention group
Group type: EXPERIMENTAL
Intervention: Imatinib for 12 months
Number of subjects: 358
Study 24737415 — intervention group
Group type: COMPARATOR
Intervention: Placebo for 12 months
Number of subjects: 358
Study 23202613 — intervention group
Group type: EXPERIMENTAL
Intervention: TRO40303
Number of subjects: 0
Study 23202613 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 18675959 — intervention group
Group type: EXPERIMENTAL
Intervention: GnRHa/chemotherapy cotreatment
Number of subjects: 80
Study 18675959 — intervention group
Group type: COMPARATOR
Intervention: Chemotherapy alone (Control)
Number of subjects: 80
Study 18065071 — intervention group
Group type: EXPERIMENTAL
Intervention: Sequential practice trials with short movement goal
Number of subjects: 20
Study 18065071 — intervention group
Group type: EXPERIMENTAL
Intervention: Sequential practice trials with long movement goal
Number of subjects: 20